Reports
Reports
Sale
The global aortic stent graft market was valued at USD 3.1 billion in 2023, with Latin America holding a significant market share. The market is driven by the growing demand for minimally invasive surgical techniques to treat vascular diseases. It is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, with the values likely to attain USD 5.2 billion by 2032.
Aortic stent grafts are tube-like devices consisting of fabric-covered metal mesh. It is used in the treatment of aortic aneurysms and helps reinforce the wall of the aorta and prevent the aneurysm from rupturing. To repair an abdominal aortic aneurysm, a minimally invasive procedure called endovascular aneurysm repair (EVAR) is performed in which an aortic stent graft is required. There is a growing preference for minimally invasive surgeries as they are associated with shorter recovery times and lower risk of complications as compared to conventional open surgeries. This rising patient inclination towards endovascular aneurysm repair is expected to drive the Latin America aortic stent graft market growth in the coming years.
Abdominal aortic aneurysm (AAA) is the most common form of aortic aneurysm and poses a significant health challenge in Latin America. Older adults tend to be more susceptible to developing the condition, with the disease reported to be highly prevalent in patients over 60 years of age. As a minimally invasive treatment option, aortic stent grafts are suitable for elderly patients who may experience higher risks in open surgical techniques due to age-related health issues. Thus, the growing aging population in the region is likely to augment the market demand for effective treatment solutions including aortic stent grafts in healthcare settings.
One of the major Latin America aortic stent graft market trends is the rising technological advancements that are leading to the development of more effective and minimally invasive stent grafts. In January 2024, W. L. Gore & Associates, Inc., a global materials science company, announced that its lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) was approved by the United States Food and Drug Administration (FDA) for treating complex vascular disease. The innovative stent graft has 6 French (Fr) compatible configurations among balloon expandable stent-grafts, offering more choices and flexibility to healthcare providers when treating patients with complicated blood vessel issues. The introduction of such advanced medical devices in Latin American countries by the key market players is expected to elevate the market value in the forecast period.
The Latin America aortic stent graft market share is also influenced by the growing number of clinical trials to evaluate the effectiveness and safety profile of new aortic stent grafts. Further, the rise in post-market surveillance studies on stent grafts and endovascular aneurysm repair such as the Global Registry for Endovascular Aortic Treatment (the GREAT registry) is expected to enhance trust among patients and healthcare providers, leading to market expansion in the region.
The report offers a detailed analysis of the market based on the following segments:
Market Breakup | Categories |
Product | Abdominal Aortic Stent Grafts, Thoracic Aortic Stent Grafts |
End User | Hospitals, Ambulatory Surgical Centers, Others |
Countries | Brazil, Argentina, Mexico, Others |
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Aortic Stent Graft Market Overview
3.1 Latin America Aortic Stent Graft Market Historical Value (2017-2023)
3.2 Latin America Aortic Stent Graft Market Forecast Value (2024-2032)
4 Latin America Aortic Stent Graft Market Landscape*
4.1 Latin America Aortic Stent Graft: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Aortic Stent Graft: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Type
4.2.3 Analysis by Application
5 Latin America Aortic Stent Graft Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Aortic Stent Graft Market Segmentation (2017-2032)
6.1 Latin America Aortic Stent Graft Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Abdominal Aortic Stent Grafts
6.1.3 Thoracic Aortic Stent Grafts
6.2 Latin America Aortic Stent Graft Market (2017-2032) by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Latin America Aortic Stent Graft Market (2017-2032) by Countries
6.3.1 Market Overview
6.3.2 Brazil
6.3.3 Argentina
6.3.4 Mexico
6.3.5 Others
7 Brazil Aortic Stent Graft Market (2017-2032)
7.1 Brazil of Aortic Stent Graft Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Abdominal Aortic Stent Grafts
7.1.3 Thoracic Aortic Stent Grafts
7.2 Brazil of Aortic Stent Graft Market (2017-2032) by End User
7.2.1 Market Overview
7.2.2 Hospitals
7.2.3 Ambulatory Surgical Centers
7.2.4 Others
8 Argentina Aortic Stent Graft Market (2017-2032)
8.1 Argentina Aortic Stent Graft Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Abdominal Aortic Stent Grafts
8.1.3 Thoracic Aortic Stent Grafts
8.2 Argentina Aortic Stent Graft Market (2017-2032) by End User
8.2.1 Market Overview
8.2.2 Hospitals
8.2.3 Ambulatory Surgical Centers
8.2.4 Others
9 Mexico Aortic Stent Graft Market (2017-2032)
9.1 Mexico Aortic Stent Graft Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Abdominal Aortic Stent Grafts
9.1.3 Thoracic Aortic Stent Grafts
9.2 Mexico Aortic Stent Graft Market (2017-2032) by End User
9.2.1 Market Overview
9.2.2 Hospitals
9.2.3 Ambulatory Surgical Centers
9.2.4 Others
10 Regulatory Framework
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Funding and Investment Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Type of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Supplier Landscape
14.1 Market Share by Top 5 Companies
14.2 Cook Medical, Inc.
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 W.l. Gore & Associates
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 MicroPort Scientific Corporation Inc.
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 Medtronic Plc.
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 Lombard Medical, Inc.
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 Endologix, INC.
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 Terumo Corporation Inc.
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certifications
14.9 Cardinal Health Inc.
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 Becton, Dickinson and Company
14.10.1 Financial Analysis
14.10.2 Product Portfolio
14.10.3 Demographic Reach and Achievements
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 Cryolife Inc.
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
15 Latin America Aortic Stent Graft – Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
18.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The Latin America aortic stent graft market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032 and is likely to reach a market value of USD 5.2 billion by 2032.
The growing demand for minimally invasive surgical techniques to treat vascular diseases is fuelling the demand for the market.
One of the significant trends in the market is the rising technological advancements that are leading to the development of more effective and minimally invasive stent grafts. In January 2024, W. L. Gore & Associates, Inc., announced the FDA approval of it lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis, aimed at treating complex vascular diseases.
Based on the product, the market is segmented into abdominal aortic stent grafts and thoracic aortic stent grafts.
End users of the market are hospitals and ambulatory surgical centers, among others.
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
The key players in the market are Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, INC., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, and CryoLife Inc.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.